Oculeve
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Oculeve sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Oculeve: 5 sponsored US clinical trials, none currently recruiting.
Oculeve sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. The most-studied condition in this pipeline is Keratoconjunctivitis Sicca, with 1 trials.
Upper-quartile sponsor footprint
Oculeve sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
NCT03097614
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
NCT02798289
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome
NCT02680158
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
NCT02526290
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation
NCT02385292
Therapeutic Areas
How the Oculeve archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Keratoconjunctivitis Sicca (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Oculeve: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Oculeve sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Oculeve page
5 registered trials is a research-attention snapshot, not an endorsement of Oculeve or any single study.
- None of Oculeve's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Keratoconjunctivitis Sicca is the condition Oculeve studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Keratoconjunctivitis Sicca trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Oculeve pipeline card: 5 registered trials from official public datasets.Report a data error.